Non Applicability of Statement of Deviation or Variation Under Reg. 32 (1) of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 for the Quarter/Half year ended 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astonea Labs Ltd has confirmed to BSE that there is no deviation or variation in the use of funds raised through its IPO conducted on 30 May 2025. The company had raised Rs. 37.67 crore via the IPO (27.9 lakh equity shares at Rs. 10 face value plus Rs. 125 premium). As per the annexure, the company has so far utilised about Rs. 25.95 crore out of the Rs. 37.67 crore raised. Working capital requirements (Rs. 19.75 crore) have been fully deployed, while proceeds for Bolivia registration (Rs. 1.29 crore) remain entirely unused, and plant & machinery (Rs. 5.23 crore allocated, ~Rs. 99 lakh used) and advertising/marketing (Rs. 4.95 crore allocated, ~Rs. 1 crore used) show partial deployment. The filing is a routine SEBI compliance submission under Regulation 32(1).
This is a routine regulatory compliance filing — no negative news for shareholders. The detailed utilisation table may help investors track how IPO proceeds are being deployed, with the slow deployment in Bolivia registration and capex being worth monitoring.